Bairitone Health - Lightning Pitch

Why It Matters

By delivering precise, at‑home airway mapping, Baritone Health could slash costs and improve success rates for sleep‑apnea therapies, reshaping a $10 billion market.

Key Takeaways

• Sleep apnea affects 30 million U.S. adults, causing dangerous suffocation events.
• Baritone Health’s wearable uses sonar to map airway acoustically at home.
• High‑resolution maps enable doctors to select optimal therapy first try.
• B2B TTOC model aligns incentives, reducing payer costs and failed procedures.
• Company seeks MTI expertise to scale from pivotal trials to production.

Summary

Baritone Health introduced a home‑based acoustic airway mapping system aimed at revolutionizing sleep‑apnea treatment. The pitch highlighted that roughly 30 million Americans suffer from the condition, yet current therapies rely on a one‑size‑fits‑all approach, leading to high failure rates and inflated insurance costs.

The company’s wearable device employs sonar sensing to generate a high‑resolution map of a patient’s airway during sleep. This data allows physicians to match individuals with the most effective therapy—whether CPAP, an implant, or alternative options—on the first attempt, potentially cutting waste and improving outcomes.

Megan Pitcher emphasized the B2B “TTOC” model that aligns economic incentives across payers, providers, and manufacturers, and noted that a lead investor has already committed to 50 % of the current funding round. She concluded with a memorable line: “We want to help you sleep like a bear without sounding like a bear.”

If successful, the technology could dramatically lower healthcare expenditures on failed procedures, accelerate personalized treatment adoption, and position Baritone Health as a key player in the growing digital‑health diagnostics market.